NVCR
Novocure Ltd - USData as of 2026 Q2 (06-30) · 13F snapshot
Summary
Novocure Ltd - US (NVCR) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$52.41M; the largest are Renaissance Technologies, Steven Cohen, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 4 added, 1 trimmed. 3 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders51 also report options
Congress trades3
Price$15.83vs quarter-end+4.49%
Sectors0
This quarter's moves
Top holderNew0
Added4
Trimmed / sold1
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $2.99M— of portfolio197,6002026 Q2
Value $286.3K— of portfolio18,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $2.99M | — | — |
| Ken GriffinPUT | $286.3K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.